Target Price | $5.50 |
Price | $5.50 |
Deviation |
0.00%
register free of charge
|
Number of Estimates | 7 |
7 Analysts have issued a price target Medical Properties Trust 2026 .
The average Medical Properties Trust target price is $5.50.
This is
0.00%
register free of charge
$9.00
63.64%
register free of charge
$3.00
45.45%
register free of charge
|
|
A rating was issued by 11 analysts: 2 Analysts recommend Medical Properties Trust to buy, 5 to hold and 4 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Medical Properties Trust stock has an average upside potential 2026 of
0.00%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Million $ | 995.55 | 945.24 |
14.19% | 5.05% | |
EBITDA Margin | 28.58% | 84.74% |
63.61% | 196.53% | |
Net Margin | -242.44% | 7.02% |
278.53% | 102.90% |
10 Analysts have issued a sales forecast Medical Properties Trust 2025 . The average Medical Properties Trust sales estimate is
This results in the following potential growth metrics:
10 Analysts have issued an Medical Properties Trust EBITDA forecast 2025. The average Medical Properties Trust EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
3 Medical Properties Trust Analysts have issued a net profit forecast 2025. The average Medical Properties Trust net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | -4.02 | 0.11 |
332.26% | 102.74% | |
P/E | 49.79 | |
EV/Sales | 12.63 |
3 Analysts have issued a Medical Properties Trust forecast for earnings per share. The average Medical Properties Trust EPS is
This results in the following potential growth metrics and future valuations:
Medical Properties Trust...
Analyst | Rating | Action | Date |
---|---|---|---|
Exane BNP Paribas |
Locked
➜
Locked
|
Locked | Mar 12 2025 |
RBC Capital |
Locked
➜
Locked
|
Locked | Mar 10 2025 |
Wells Fargo |
Locked
➜
Locked
|
Locked | Mar 10 2025 |
Truist Securities |
Locked
➜
Locked
|
Locked | Dec 19 2024 |
Mizuho |
Locked
➜
Locked
|
Locked | Dec 05 2024 |
Colliers Securities |
Locked
➜
Locked
|
Locked | Sep 13 2024 |
Truist Securities |
Locked
➜
Locked
|
Locked | Sep 13 2024 |
Analyst Rating | Date |
---|---|
Locked
Exane BNP Paribas:
Locked
➜
Locked
|
Mar 12 2025 |
Locked
RBC Capital:
Locked
➜
Locked
|
Mar 10 2025 |
Locked
Wells Fargo:
Locked
➜
Locked
|
Mar 10 2025 |
Locked
Truist Securities:
Locked
➜
Locked
|
Dec 19 2024 |
Locked
Mizuho:
Locked
➜
Locked
|
Dec 05 2024 |
Locked
Colliers Securities:
Locked
➜
Locked
|
Sep 13 2024 |
Locked
Truist Securities:
Locked
➜
Locked
|
Sep 13 2024 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.